title: Zanamivir for the treatment of influenza in adults: a systematic review and economic evaluation.
authors.affiliation: Department of Public Health and Epidemiology, University of Birmingham, UK.
authors.forename: A
authors.initials: A
authors.lastname: Burls
authors.forename: W
authors.initials: W
authors.lastname: Clark
authors.forename: T
authors.initials: T
authors.lastname: Stewart
authors.forename: C
authors.initials: C
authors.lastname: Preston
authors.forename: S
authors.initials: S
authors.lastname: Bryan
authors.forename: T
authors.initials: T
authors.lastname: Jefferson
authors.forename: A
authors.initials: A
authors.lastname: Fry-Smith
mesh_terms: D000328:Adult; D000998:Antiviral Agents / Q000009:adverse effects / Q000191:economics* / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D006146:Guanidines; D006801:Humans; D007251:Influenza, Human / Q000188:drug therapy*; D011714:Pyrans; D016032:Randomized Controlled Trials as Topic; D012794:Sialic Acids / Q000009:adverse effects / Q000191:economics* / Q000627:therapeutic use*; D016896:Treatment Outcome; D006113:United Kingdom; D053243:Zanamivir
chemical_list: D000998:Antiviral Agents; D006146:Guanidines; D011714:Pyrans; D012794:Sialic Acids; D053243:Zanamivir